Pulse Explorer nav.journalClub Débats Tendances Chercheurs Revues

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

February 8, 2026Haematologica0 citationsOpen Access

Post-CAR-T lymphocytosis in multiple myeloma: too much of a good thing?

GCGuiZhen Chen RBRahul Banerjee

Key Points

To evaluate the implications of lymphocytosis following CAR-T therapy in patients with multiple myeloma.
Analysis of lymphocyte counts post-CAR-T treatment
Evaluation of immune response metrics
Assessment of therapeutic outcomes related to lymphocytosis
Increased lymphocyte counts observed post-CAR-T treatment
Potential correlations between lymphocytosis and treatment response
Further investigation needed to understand advantages or risks of high lymphocyte levels

Abstract

Not available.

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Post-CAR-T lymphocytosis in multiple myeloma: too much of a good thing? | Synapse

Cite This Study

Chen et al. (Thu,) studied this question.

synapsesocial.com/papers/698828b90fc35cd7a884880d https://doi.org/https://doi.org/10.3324/haematol.2025.300428